1. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma
    Paola Caria et al, 2016, International Journal of Molecular Sciences CrossRef
  2. Mutations inTERTpromoter andFGFR3and telomere length in bladder cancer
    Ismail Hosen et al, 2015, International Journal of Cancer CrossRef
  3. Correlation of telomere length to malignancy potential in non‑melanoma skin cancers
    Hanae Yamada‑Hishida et al, 2017, Oncology Letters CrossRef
  4. EGFR and HER2 Expression in Papillary Thyroid Carcinoma
    Yong-Seon Kim et al, 2018, Journal of Endocrine Surgery CrossRef
  5. Biological Differential Diagnosis of Follicular Thyroid Tumor and Hürthle Cell Tumor on the Basis of Telomere Length and hTERT Expression
    Yoshiyuki Sugishita et al, 2014, Annals of Surgical Oncology CrossRef
  6. Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer
    WOJCIECH BARCZAK et al, 2016, Oncology Letters CrossRef
  7. HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin
    Rosaria Ruggeri et al, 2016, International Journal of Molecular Sciences CrossRef
  8. Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
    Valerie Jacquemin et al, 2022, Cancers CrossRef